Concepedia

Geneviève Gueguen‐Dorbes

GG

3

Publications

119

Citations

3

H-Index

2012

Active since

Affiliations

Sanofi (France)(Current)

Geneviève Gueguen‐Dorbes is an author at Sanofi (France) specializing in radiation oncology, tumor biology, and cancer research.

Top concepts

MedicineTumor BiologyCancer ResearchRadiation OncologyOncologyImmunologyLung CancerAngiogenesisCell BiologyPharmacology

Publications per year

2012–2022

3

Publications

3

SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

Antoine Alam, Isabelle Blanc, Geneviève Gueguen‐Dorbes et al. · Molecular Cancer Therapeutics · 2012 · 83 citations

Tam Invasion, Oncology, Medicine +13

Tumor Vasculature Is Regulated by FGF/FGFR Signaling‐Mediated Angiogenesis and Bone Marrow‐Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRs

Pierre Fons, Geneviève Gueguen‐Dorbes, Jean-Pascal Hérault et al. · Journal of Cellular Physiology · 2014 · 25 citations

Tumor Biology, Tumor Angiogenesis, Angiogenesis +17

Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy

Michaël R. Paillasse, Michaël Esquerré, Florie A. Bertrand et al. · Cancer Research Communications · 2022 · 11 citations · Full text

Rows per page

1–3 of 3